Decision Diagnostics Net Income
| DECN Stock | USD 0.0001 0.00 0.00% |
Decision Diagnostics technical analysis allows you to utilize historical prices and volume patterns in order to determine a pattern that computes the direction of the firm's future prices.
Decision Diagnostics Total Revenue |
|
Gross Profit | Market Capitalization | Enterprise Value Revenue 1.4379 | Revenue | Earnings Share (0.02) |
| Last Reported | Projected for Next Year | ||
| Net Loss | -26.7 M | -25.4 M | |
| Net Loss | -26.7 M | -25.4 M | |
| Net Loss | -26.7 M | -25.4 M | |
| Net Loss | (0.10) | (0.11) | |
| Net Income Per E B T | 0.90 | 0.60 |
Decision | Net Income | Build AI portfolio with Decision Stock |
Evaluating Decision Diagnostics's Net Income across multiple reporting periods reveals the company's ability to sustain growth and manage resources effectively. This longitudinal analysis highlights inflection points, cyclical patterns, and structural changes that short-term snapshots might miss, offering deeper insight into Decision Diagnostics's fundamental strength.
Latest Decision Diagnostics' Net Income Growth Pattern
Below is the plot of the Net Income of Decision Diagnostics over the last few years. Net income is one of the most important fundamental items in finance. It plays a large role in Decision Diagnostics financial statement analysis. It represents the amount of money remaining after all of Decision Diagnostics operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue. It is Decision Diagnostics' Net Loss historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Decision Diagnostics' overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported (29.67 M) | 10 Years Trend |
|
Net Income |
| Timeline |
Decision Net Income Regression Statistics
| Arithmetic Mean | (13,054,317) | |
| Geometric Mean | 6,688,315 | |
| Coefficient Of Variation | (103.59) | |
| Mean Deviation | 12,827,214 | |
| Median | (3,132,295) | |
| Standard Deviation | 13,522,418 | |
| Sample Variance | 182.9T | |
| Range | 31.4M | |
| R-Value | (0.85) | |
| Mean Square Error | 53T | |
| R-Squared | 0.73 | |
| Significance | 0.000013 | |
| Slope | (2,284,999) | |
| Total Sum of Squares | 2925.7T |
Decision Net Income History
Other Fundumenentals of Decision Diagnostics
| Net Income From Continuing Ops | ||
| Net Income Applicable To Common Shares | ||
| Net Income Per Share | ||
| Net Income Per E B T |
Decision Diagnostics Net Income component correlations
Decision Net Income Driver Correlations
Understanding the fundamental principles of building solid financial models for Decision Diagnostics is extremely important. It helps to project a fair market value of Decision Stock properly, considering its historical fundamentals such as Net Income. Since Decision Diagnostics' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Decision Diagnostics' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Decision Diagnostics' interrelated accounts and indicators.
Click cells to compare fundamentals
Will Health Care Technology sector continue expanding? Could Decision diversify its offerings? Factors like these will boost the valuation of Decision Diagnostics. Projected growth potential of Decision fundamentally drives upward valuation adjustments. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Decision Diagnostics data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share (0.02) | Revenue Per Share | Quarterly Revenue Growth (0) | Return On Assets | Return On Equity |
Understanding Decision Diagnostics requires distinguishing between market price and book value, where the latter reflects Decision's accounting equity. The concept of intrinsic value - what Decision Diagnostics' is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Market sentiment, economic cycles, and investor behavior can push Decision Diagnostics' price substantially above or below its fundamental value.
It's important to distinguish between Decision Diagnostics' intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Decision Diagnostics should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. In contrast, Decision Diagnostics' trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.
Decision Diagnostics 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Decision Diagnostics' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Decision Diagnostics.
| 11/06/2025 |
| 02/04/2026 |
If you would invest 0.00 in Decision Diagnostics on November 6, 2025 and sell it all today you would earn a total of 0.00 from holding Decision Diagnostics or generate 0.0% return on investment in Decision Diagnostics over 90 days. Decision Diagnostics is related to or competes with Ligand Pharmaceuticals. Decision Diagnostics Corp. develops smart phone based electronic medical record technologies More
Decision Diagnostics Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Decision Diagnostics' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Decision Diagnostics upside and downside potential and time the market with a certain degree of confidence.
Decision Diagnostics Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Decision Diagnostics' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Decision Diagnostics' standard deviation. In reality, there are many statistical measures that can use Decision Diagnostics historical prices to predict the future Decision Diagnostics' volatility.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Decision Diagnostics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Decision Diagnostics Backtested Returns
We have found three technical indicators for Decision Diagnostics, which you can use to evaluate the volatility of the firm. The firm shows a Beta (market volatility) of 0.0, which means not very significant fluctuations relative to the market. the returns on MARKET and Decision Diagnostics are completely uncorrelated.
Auto-correlation | 1.00 |
Perfect predictability
Decision Diagnostics has perfect predictability. Overlapping area represents the amount of predictability between Decision Diagnostics time series from 6th of November 2025 to 21st of December 2025 and 21st of December 2025 to 4th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Decision Diagnostics price movement. The serial correlation of 1.0 indicates that 100.0% of current Decision Diagnostics price fluctuation can be explain by its past prices.
| Correlation Coefficient | 1.0 | |
| Spearman Rank Test | 1.0 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Decision Operating Income
Operating Income |
|
Based on the recorded statements, Decision Diagnostics reported net income of (29.67 Million). This is 108.69% lower than that of the Health Care Technology sector and significantly lower than that of the Health Care industry. The net income for all United States stocks is 105.2% higher than that of the company.
Decision Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Decision Diagnostics' direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Decision Diagnostics could also be used in its relative valuation, which is a method of valuing Decision Diagnostics by comparing valuation metrics of similar companies.Decision Diagnostics is currently under evaluation in net income category among its peers.
Decision Fundamentals
| Return On Equity | -81.61 | ||||
| Return On Asset | -0.21 | ||||
| Operating Margin | (0.95) % | ||||
| Current Valuation | 3.06 M | ||||
| Shares Outstanding | 357.87 M | ||||
| Price To Earning | (0.33) X | ||||
| Price To Book | 2.72 X | ||||
| Price To Sales | 0.02 X | ||||
| Revenue | 1.98 M | ||||
| Gross Profit | 462.23 K | ||||
| EBITDA | (2.41 M) | ||||
| Net Income | (29.67 M) | ||||
| Cash And Equivalents | 210.85 K | ||||
| Total Debt | 2.93 M | ||||
| Debt To Equity | 9.05 % | ||||
| Current Ratio | 0.25 X | ||||
| Cash Flow From Operations | (1.4 M) | ||||
| Earnings Per Share | (0.02) X | ||||
| Beta | -0.097 | ||||
| Market Capitalization | 35.79 K | ||||
| Total Asset | 5.65 M | ||||
| Retained Earnings | (79.4 M) | ||||
| Working Capital | (3.3 M) | ||||
| Current Asset | 4.3 M | ||||
| Current Liabilities | 3.06 M | ||||
| Net Asset | 5.65 M |
About Decision Diagnostics Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Decision Diagnostics's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Decision Diagnostics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Decision Diagnostics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
When determining whether Decision Diagnostics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Decision Diagnostics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Decision Diagnostics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Decision Diagnostics Stock: Check out To learn how to invest in Decision Stock, please use our How to Invest in Decision Diagnostics guide.You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.
Will Health Care Technology sector continue expanding? Could Decision diversify its offerings? Factors like these will boost the valuation of Decision Diagnostics. Projected growth potential of Decision fundamentally drives upward valuation adjustments. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Decision Diagnostics data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share (0.02) | Revenue Per Share | Quarterly Revenue Growth (0) | Return On Assets | Return On Equity |
Understanding Decision Diagnostics requires distinguishing between market price and book value, where the latter reflects Decision's accounting equity. The concept of intrinsic value - what Decision Diagnostics' is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Market sentiment, economic cycles, and investor behavior can push Decision Diagnostics' price substantially above or below its fundamental value.
It's important to distinguish between Decision Diagnostics' intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Decision Diagnostics should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. In contrast, Decision Diagnostics' trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.